2011 to 2022 Saw Decline in Cost-Related Asthma Medication Nonadherence

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 11, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Dec. 10, 2024 -- For adults with asthma, the prevalence of cost-related medication nonadherence (CRN) decreased from 2011 to 2022, according to a study published online Dec. 9 in Thorax.

Chun-Tse Hung, Pharm.D., from Taipei Medical University in Taiwan, and colleagues used data from the 2011 to 2022 National Health Interview Survey to examine trends, prevalence, and determinants of CRN and its impact on asthma control among U.S. adults with asthma. Data were included for 30,793 adults with asthma, representing 8.1 percent of the U.S. population.

The researchers observed a declining trend in the prevalence of CRN among U.S. adults with asthma from 2011 to 2022. Due to cost, about one in six adults with asthma were nonadherent to medications. Factors that were associated with CRN included demographics and comorbidities. The risk for experiencing asthma attacks and emergency department visits for asthma was increased among adults with asthma who had CRN (adjusted odds ratios, 1.95 and 1.63, respectively).

"Since asthma is one of the leading chronic diseases, the burden in cost-related nonadherence to medications highlights the need for appropriate policies and social support to address such problems," the authors write.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-12-12 00:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords